亿帆医药：合肥欣竹生产线近期投入使用，目前有2款生物类似物产品进行试生产

Group 1 - The core point of the news is that the Hefei Xinzhu Biotechnology project has recently commenced production, with two biosimilar products currently in trial production [2][3]. Group 2 - Hefei Xinzhu Biotechnology's production line has been put into operation, indicating a significant development in the company's manufacturing capabilities [2]. - The company, Yifan Pharmaceutical (002019.SZ), confirmed the initiation of production at the Hefei Xinzhu facility on September 9, highlighting its commitment to expanding its product offerings in the biosimilar market [2].